Search research articles
Contact Us
Filters
Showing results (31-40 of 92) with videos related to
Page
of 10
Sort By:
Medical Mycology
|
April 2, 2020
NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile
Derry K Mercer, Jennifer C Robertson, Lorna Miller, et al.
FEMS Microbiology Letters
|
June 27, 2001
Transformation of an oral bacterium via chromosomal integration of free DNA in the presence of human saliva
D K Mercer, K P Scott, C M Melville, et al.
Life Sciences
|
July 9, 2009
6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice
Janet E Yancey-Wrona, Tyler J Raymond, Hannah K Mercer, et al.
ISME Communications
|
November 8, 2023
Revealing the uncharacterised diversity of amphibian and reptile viruses
Emma F Harding, Alice G Russo, Grace J H Yan, et al.
Molecular Biology and Evolution
|
August 5, 2024
Invasion and Amplification of Endogenous Retroviruses in Dasyuridae Marsupial Genomes
Emma F Harding, Lewis K Mercer, Grace J H Yan, et al.
Applied and Environmental Microbiology
|
January 5, 1999
Fate of free DNA and transformation of the oral bacterium Streptococcus gordonii DL1 by plasmid DNA in human saliva
D K Mercer, K P Scott, W A Bruce-Johnson, et al.
Chest
|
October 29, 1998
Perception of fatigue and quality of life in patients with COPD
E Breslin, C van der Schans, S Breukink, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2017
NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus
Derry K Mercer, Laura K Katvars, Fiona Hewitt, et al.
Nature
|
April 27, 2001
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
L Johnson, K Mercer, D Greenbaum, et al.
Antimicrobial Agents and Chemotherapy
|
March 13, 2019
Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate
Derry K Mercer, Colin S Stewart, Lorna Miller, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 92) with videos related to
Sort By:
Page
of 10
Medical Mycology
|
April 2, 2020
NP213 (Novexatin®): A unique therapy candidate for onychomycosis with a differentiated safety and efficacy profile
Derry K Mercer, Jennifer C Robertson, Lorna Miller, et al.
FEMS Microbiology Letters
|
June 27, 2001
Transformation of an oral bacterium via chromosomal integration of free DNA in the presence of human saliva
D K Mercer, K P Scott, C M Melville, et al.
Life Sciences
|
July 9, 2009
6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice
Janet E Yancey-Wrona, Tyler J Raymond, Hannah K Mercer, et al.
ISME Communications
|
November 8, 2023
Revealing the uncharacterised diversity of amphibian and reptile viruses
Emma F Harding, Alice G Russo, Grace J H Yan, et al.
Molecular Biology and Evolution
|
August 5, 2024
Invasion and Amplification of Endogenous Retroviruses in Dasyuridae Marsupial Genomes
Emma F Harding, Lewis K Mercer, Grace J H Yan, et al.
Applied and Environmental Microbiology
|
January 5, 1999
Fate of free DNA and transformation of the oral bacterium Streptococcus gordonii DL1 by plasmid DNA in human saliva
D K Mercer, K P Scott, W A Bruce-Johnson, et al.
Chest
|
October 29, 1998
Perception of fatigue and quality of life in patients with COPD
E Breslin, C van der Schans, S Breukink, et al.
Antimicrobial Agents and Chemotherapy
|
June 14, 2017
NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus
Derry K Mercer, Laura K Katvars, Fiona Hewitt, et al.
Nature
|
April 27, 2001
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
L Johnson, K Mercer, D Greenbaum, et al.
Antimicrobial Agents and Chemotherapy
|
March 13, 2019
Improved Methods for Assessing Therapeutic Potential of Antifungal Agents against Dermatophytes and Their Application in the Development of NP213, a Novel Onychomycosis Therapy Candidate
Derry K Mercer, Colin S Stewart, Lorna Miller, et al.
Page
of 10